NCT06195605
Investigating Age Dependence of Fibroblast and Extracellular Matrix Responses to Cross-linked Hyaluronic Acid Filler in Human Skin
StatusActive, Not Recruiting
PhaseNot applicable
SponsorUniversity of Michigan
Primary completion (estimated)
At risk: Primary completion moved at least 11 months later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 6 versions: 5 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗
- Notable Primary completion pushed from Nov 2026 to Nov 2027
- Eligibility criteria expanded, about 19 words
- Study completion pushed from Feb 2027 to Feb 2028
- Collaborators: details revised at 1 of 1 entry
- Minor Enrollment closed, study ongoing
- Study completion pushed from Nov 2026 to Feb 2027
- Site details revised
- Notable Trial status: Not Yet Recruiting to Recruiting
- Start date changed from estimate of Apr 2024 to May 9, 2024
- Site details revised
- Notable Primary and study completion dates: Nov 2025 to Nov 2026
- Start date: Jan 2024 to Apr 2024
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Extracellular Matrix (ECM) deposition as measured using histological stain(s) of skin
Timeframe: Approximately 4 weeks
Arms and interventions
Photodamaged skinExperimental
Devices: Restylane-L, Vehicle
Sites
1 site in 1 country
- University of MichiganAnn Arbor, Michigan, United States